Skip to main content
Signal8

Boyd Peter E.

SEC insider (Form 3/4/5 filer). CIK 0001739816. Chief People Officer at Aquestive Therapeutics, Inc. (AQST). 12 reported Form 4/5 transactions since Sep 2024; latest on Sep 9, 2026. Located in WARREN, NJ.

Companies Boyd Peter E. has filed insider reports for

  • Aquestive Therapeutics, Inc. (AQST): Officer, Chief People Officer
Boyd Peter E. profile photo

Boyd Peter E.

CIK: 0001739816

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Aquestive Therapeutics, Inc. logo
AQST

Aquestive Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Sep 9, 2026
    In-the-Money
    Direct
    2.3K shares at avg. $0.96$2K
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    May 5, 2026
    Tax Payment
    Direct
    56.8K shares at avg. $4.18$237K
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Mar 10, 2026
    Sale
    Direct
    29.8K shares at avg. $4.17$124K
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Mar 9, 2026
    Award
    Direct
    80K shares-
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Dec 4, 2025
    Award
    Direct
    20K shares-
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Oct 15, 2025
    Sale
    Direct
    10K shares at avg. $7.00$70K
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Sep 26, 2025
    Sale
    Direct
    10K shares at avg. $6.30$63K
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Sep 5, 2025
    Sale
    Direct
    15K shares at avg. $5.30$80K
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Mar 9, 2025
    Tax Payment
    Direct
    7.7K shares at avg. $2.65$20K
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Mar 7, 2025
    Award

    Performance Stock Units

    Direct
    60K shares-

1-10 of 12